Stock Price Prediction

BioVie (BIVI) stock has shown extreme volatility recently, surging 98.7% to $4.67 in pre-market trading on October 21, 2024, but later dropping 56% to $1.24 due to a $3 million secondary offering priced at $1.53 per share. Bulls may argue that the stock's potential lies in its innovative treatments and speculative appeal, but the dilution and sharp price swings highlight significant risks.

Bears view BioVie Inc. (BIVI) stock negatively due to its recent 56% drop to $1.24 following a $3M secondary offering priced at $1.53, signaling dilution concerns. The stock's inability to sustain gains after a 98.7% pre-market surge highlights volatility and weak investor confidence. Additionally, its financial instability and reliance on offerings make it a high-risk investment.